himachalol has been researched along with Cancer of Skin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Daher, CF; Daher, JC; Dwairi, V; El Jalbout, ND; Elias, A; Ibrahim, P; Iskandar, R; Mroueh, M; Nehme, B; Saad, JM; Shebaby, W; Taleb, RI; Zgheib, M | 1 |
1 other study(ies) available for himachalol and Cancer of Skin
Article | Year |
---|---|
Himachalol induces apoptosis in B16-F10 murine melanoma cells and protects against skin carcinogenesis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzocycloheptenes; Cedrus; Cell Cycle Checkpoints; Cell Survival; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Male; MAP Kinase Signaling System; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Phosphatidylinositol 3-Kinase; Polycyclic Sesquiterpenes; Proto-Oncogene Proteins c-akt; Skin Neoplasms; Time Factors | 2020 |